News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

T2 Biosystems Expands Intellectual Property Portfolio Covering T2MR® Direct Detection Diagnostic Platform


10/22/2013 10:06:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued two patents adding depth and breadth to the protection of the Company’s T2MR® platform and the T2Dx® detection system. Both patents are part of the growing intellectual property estate protecting T2 Bio’s breakthrough detection capabilities, including the Company’s flagship T2Candida® multiplex test panel that detects the presence of species-specific Candida directly from whole blood in approximately three hours without the requirement for blood culturing.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES